[1] Morrell NW, Danto S, Archer SL,et al. Cellular and
molecular basis of pulmonary arterial hypertension [J]. Am
Cull Cordial,2009,54(1):S20-S31.
[2] 杨明高,范俊德.三拗芎葶汤治疗COPD急性发作108例临床观
察[J].湖北中医杂志,2004,26(11):28-29.
[3] Task Force for Diagnosis and Treatment of Pulmonary
Hypertension of European Society of Cardiology (ESC),
European Respiratory Society (ERS) , International Soci-ety of Heart and Lung Transplantation (ISHLT), et al.
Guidelines for the diagnosis and treatment of pulmonary
hypertension [J]. Eur Respir J,2009,34:1219-1263.
[4] McLaughlin VV, Archer SL, Badesch DB,et al. ACCF/
AHA2009 expert consensus document on pulmonary hy-pertension a report of the American College of Cardiology
Foundation Task Force on Expert Consensus Documents
and the American Heart Association developed in collabo-ration with the American College of Chest Physicians;
American Thoracic Society, Inc.; and the Pulmonary Hy-pertension Association [J]. J Am Coll Cardiol, 2009,53:
1573-1619.
[5] 何建国,郭英华.规范肺动脉高压的诊断与治疗[J].中国循环杂
志,2007,22:73-74.
[6] 陈灏珠,林果为,王吉耀.实用内科学[M].14版,北京:人民卫生出
版,2014:1570-1572,1694,1696.
[7] 王永炎,鲁兆麟.中医药学高级丛书-中医内科学[M].北京:人民
卫生出版社,1999:199-200.
[8] 李德新,刘燕池.中医药学高级丛书-中医基础理论[M].2版,北
京:人民卫生出版社,2011:543-544.
[9] 丁丽丽,施松善,崔健.麻黄化学成分与药理作用研宄进展[J].中
国中药杂志,2006,31(20):1661-1664.
[10] 钟凌云,祝婧,龚千锋,等.炮制对麻黄发汗、平喘药效影响研究
[J]. 中药药理与临床,2008,24(6):53-56.
[11] 吉宁飞,殷凯生.川芎嗪治疗支气管哮喘的研究进展[J].中国厂学
医学.2006,19(3):270-271.
[12] 刘忠,李永春.川芎嗪对慢性阻塞性肺疾病模型大鼠肺泡中肿瘤
坏死因子-a的影响[J].中国老年学杂志,2009,29(5):1092-1094.
[13] 柏正平,郑兵,卜献春,周东阳.复方葶苈子胶囊止咳祛疯作用的
实验研究[J].湖南中医药导报,2000,6(5):53.
[14] 郭娟,陈长勋,沈云辉.葶苈子水提液对动物实验性心室重构的影
响[J].中草药,2007,38(10):1519-1523.
[15] 王道芳.浅述桃仁与苦杏仁的药理及临床应用[J].基层中药杂志,
2002,16(6):61-62.